Quit Genius Funding & Investors
Quit Genius is the world’s first digital clinic for treating nicotine, alcohol and opioid addictions. Built on the evidence-based approach of Medication-Assisted Treatment (MAT), Quit Genius combines virtual cognitive behavioral therapy (CBT) with approved medication and connected devices to help employers and health plans tackle the high cost of addiction, while improving the lives of their employees and members.
quitgenius.comTotal Amount Raised: $78,600,000
Quit Genius Funding Rounds
Series B
$64,000,000
Series B Investors
Triple PointStartup HealthHealthcare Co-opAtomicoOctopus VenturesKinnevikSeries A
$12,000,000
Series A Investors
Triple PointBurda Principal InvestmentsStartup HealthVenus WilliamsCur8 CapitalY CombinatorOctopus VenturesSerena VenturesSeed
$2,600,000
Seed Investors
Village GlobalAAF ManagementMax MullenPioneer FundForce Over Mass CapitalOlivia TeichJuha PaananenMerckY CombinatorJunaid BajwaTelefónicaDavid LangerPaul RosaniaEric RiesEQT VenturesLionheart Ventures
Funding info provided by Diffbot.